Illumina, Inc. (BVMF:I1LM34)

Market Cap	119.20B
Revenue (ttm)	22.91B
Net Income (ttm)	3.76B
Shares Out	n/a
EPS (ttm)	23.83
PE Ratio	31.74
Forward PE	29.25
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,564
Average Volume	258
Open	160.64
Previous Close	n/a
Day's Range	155.37 - 162.56
52-Week Range	83.58 - 167.15
Beta	1.41
RSI	66.87
Earnings Date	Feb 5, 2026

About Illumina

Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1998
• Employees: 9,030
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: I1LM34

Financial Performance

In 2024, Illumina's revenue was $4.37 billion, a decrease of -2.93% compared to the previous year's $4.50 billion. Losses were -$1.22 billion, 5.34% more than in 2023.

Financial numbers in USD